What are the changes in the variable region of immunoglobulins?
What is the primary use of the Hybridoma technique?
Which of the following statements about interleukin-1 is false?
All are true regarding the development of T-cells, except?
Which cytokine activates macrophages?
Which of the following is considered the most professional antigen presenting cell (APC) in the immune system?
Which part of bacteria is most antigenic?
When is the prozone phenomenon seen?
Which immunoglobulin is the most efficient at activating the classical complement pathway?
Opsonization takes place through -
Explanation: ***Idiotype*** - **Idiotype** refers to the unique set of antigenic determinants in the **variable region** of an antibody molecule, specifically within the **hypervariable regions (complementarity-determining regions, CDRs)**. - These unique determinants allow antibodies to recognize specific antigens and are generated by the specific **V(D)J gene rearrangements** in B cells. *Isotype* - **Isotype** refers to the constant region of an antibody, determining its class (e.g., **IgG, IgM, IgA, IgD, IgE**). - This region defines the antibody's effector functions and has nothing to do with the antigen-binding variability. *Allotype* - **Allotype** refers to minor genetic variations within the **constant region** of an antibody molecule within a species. - These variations are due to different alleles inherited from parents and are not associated with the variable region that binds to antigens. *Epitope* - An **epitope** is the specific part of an **antigen** that an antibody or T-cell receptor recognizes and binds to. - It is a feature of the antigen, not a change within the variable region of the immunoglobulin itself.
Explanation: ***Monoclonal antibodies*** - The **hybridoma technique** is primarily used to produce **monoclonal antibodies (MAbs)**, which are highly specific antibodies derived from a single B-cell clone. - These antibodies recognize a **single epitope** on an antigen, providing exceptional specificity and uniformity. - The technique involves **fusing a B-lymphocyte** (antibody-producing cell) with a **myeloma cell** (immortal cancer cell) to create a hybridoma that continuously produces identical antibodies. - This is the **gold standard** for producing large quantities of identical, highly specific antibodies for diagnostic and therapeutic use. *Specific antibodies* - While monoclonal antibodies are indeed specific, this term is **too vague** and could refer to any antibody with specificity, including polyclonal antibodies. - **Polyclonal antibodies** are also specific but are produced through conventional immunization, not the hybridoma technique. - The defining characteristic of the hybridoma technique is that it produces **monoclonal** (single clone) antibodies, not just "specific" ones. *Antigen* - An **antigen** is a molecule that elicits an immune response and is used to immunize animals during antibody production. - However, antigens are the **input** for antibody production, not the **product** of the hybridoma technique. *Cytokines* - **Cytokines** are signaling molecules involved in immune cell communication and regulation. - They are not produced by the hybridoma technique, which is specifically designed for **antibody production**.
Explanation: ***IL-1 inhibits IL-2 production by T-cells*** - This statement is false because **IL-1** actually **enhances the production of IL-2** by T-cells, which is crucial for T-cell proliferation and immune response. - **IL-1 acts synergistically with IL-6 and TNF-α** to promote inflammation and immune cell activation, where IL-2 plays a key role. *The primary source of IL-1 is the monocyte-macrophage system* - This statement is true; **monocytes and macrophages** are the main producers of **IL-1α and IL-1β** upon activation by various stimuli. - Other cells, such as neutrophils, dendritic cells, and endothelial cells, can also produce IL-1, but monocytes and macrophages are the predominant source. *IL-1 is an endogenous pyrogen* - This statement is true; **IL-1** is a potent **endogenous pyrogen** that acts on the hypothalamus to induce fever, a hallmark of the acute phase response. - It triggers prostaglandin synthesis in the hypothalamus, leading to an elevation in the body's thermoregulatory set point. *IL-1 promotes acute phase protein synthesis in the liver* - This statement is true; **IL-1** is a key mediator that stimulates **hepatocytes** to produce **acute phase proteins**, such as C-reactive protein and serum amyloid A. - This hepatic response is part of the innate immune system's effort to control infection and inflammation.
Explanation: ***T-cells are located in mantle layer of spleen*** - The **mantle layer** (or marginal zone) of the spleen is primarily associated with **B-lymphocytes**, which are involved in antibody production. - While T-cells are present in the spleen, they are predominantly found in the **periarteriolar lymphoid sheath (PALS)**, which is part of the white pulp, rather than the mantle layer. *T-cells are formed in bone marrow* - **Hematopoietic stem cells** in the **bone marrow** are the progenitors of all blood cells, including lymphocytes. - These stem cells differentiate into **lymphoid stem cells**, which then travel to the thymus to become T-cells. *Maturation of T-cells take place in thymus* - **T-cell precursors** migrate from the bone marrow to the **thymus**, where they undergo a complex process of differentiation and selection. - In the thymus, T-cells acquire their **T-cell receptors (TCRs)** and undergo positive and negative selection to ensure they are self-MHC restricted and tolerant to self-antigens. *In lymph nodes, T-cells are found in paracortical area* - The **paracortical area** (or paracortex) of the lymph node is the **T-cell zone**, rich in T-lymphocytes and dendritic cells. - This region is crucial for the interaction between T-cells and antigen-presenting cells, initiating adaptive immune responses.
Explanation: ***IFN-γ (Interferon-gamma)*** - **IFN-γ is the classic macrophage-activating cytokine**, enhancing phagocytic and antimicrobial functions - Promotes expression of **MHC class I and II molecules**, increasing antigen presentation capacity - Produced mainly by **Th1 cells and NK cells** during cell-mediated immunity - Key cytokine in defense against **intracellular pathogens** (mycobacteria, viruses) *IL-8* - **IL-8 is a chemokine** (cytokine subfamily) primarily involved in **neutrophil chemotaxis** - Recruits neutrophils to sites of infection or inflammation - Does not directly activate macrophages like IFN-γ - Important in acute inflammatory responses *PAF (Platelet-Activating Factor)* - **Not a cytokine** - it is a **phospholipid mediator** - Involved in allergic and inflammatory responses - Functions include **platelet aggregation**, **vasodilation**, and **bronchoconstriction** - While it affects immune responses, it doesn't function as a macrophage-activating cytokine *Leukotriene B4* - **Not a cytokine** - it is a **lipid mediator** (eicosanoid) derived from arachidonic acid - Primarily acts as a **chemoattractant for neutrophils** - Promotes neutrophil and monocyte adhesion and migration to inflammatory sites - Does not directly activate macrophages
Explanation: ***Dendritic cells*** - **Dendritic cells** are specialized for capture, processing, and presentation of antigens to T lymphocytes. - They are often referred to as the "**professional APCs**" due to their superior ability to initiate primary T cell responses. *B cells* - While B cells can present antigens, they are generally less efficient than **dendritic cells** and primarily serve to present antigens to **helper T cells** during secondary immune responses. - Their main role is **antibody production** after activation, not initiating primary T cell responses. *T cells* - **T cells** are effector cells of the adaptive immune system and recognize antigen presented by APCs; they do not typically function as antigen-presenting cells themselves. - Some T cells, like **gamma-delta T cells**, can present antigens, but this is not their primary role. *NK cells* - **Natural Killer (NK) cells** are part of the innate immune system and primarily target and kill infected or cancerous cells without prior sensitization. - They do not present antigens in the classical sense and are not considered professional APCs.
Explanation: ***Lipopolysaccharide (LPS)*** - The **O antigen** (polysaccharide component of LPS) in Gram-negative bacteria is one of the **most antigenic** bacterial components - Highly **immunogenic**, inducing strong antibody responses (both IgM and IgG) - Used as the basis for **serological typing** of Gram-negative bacteria (e.g., E. coli O157:H7) - The polysaccharide chains are structurally diverse with multiple epitopes, creating strain-specific immunity - While lipid A component has endotoxin activity, the polysaccharide portion is the primary antigenic determinant *Protein coat* - Bacterial **surface proteins** (flagella, pili, outer membrane proteins) are indeed antigenic - However, **polysaccharides** (including capsular polysaccharides and LPS) are classically considered more potent antigens - The term "protein coat" is also somewhat non-specific in bacteriology *Nucleic acid* - **Nucleic acids** (DNA, RNA) are generally **poor antigens** on their own - Not readily accessible to antibodies as they are intracellular - Can act as pathogen-associated molecular patterns (PAMPs) for innate immunity via TLRs, but are not major antibody targets *Lipids* - **Lipids** alone are generally **non-immunogenic** due to lack of structural complexity - Too small and lack sufficient epitopes to stimulate B cell responses effectively - May act as **haptens** requiring conjugation to carrier proteins
Explanation: ***Antibody excess to antigen*** - The **prozone phenomenon** occurs when there is a significant **excess of antibodies** relative to the antigen, leading to inhibition of lattice formation. - In this state, too many antibodies bind to individual antigen sites, preventing cross-linking and thus inhibiting visible **agglutination** or **precipitation**. *Same concentration of antibody and antigen* - This scenario typically represents the **zone of equivalence**, where optimal lattice formation and visible reaction (agglutination or precipitation) occur. - It is where the concentrations of antibody and antigen are balanced, leading to maximum complex formation. *In antigen excess to antibody* - This situation is known as the **postzone phenomenon**, where an excess of antigen prevents the formation of stable antibody-antigen complexes. - The antigen saturates the limited antibody sites, resulting in no or minimal visible reaction. *Hyperimmune reaction* - A hyperimmune reaction refers to an **exaggerated immune response**, often resulting from repeated exposure to an antigen. - While it involves high antibody levels, it is a clinical state rather than a specific phenomenon describing antibody-antigen ratios in *in vitro* tests.
Explanation: ***IgM*** - **IgM** is a **pentamer** with **ten antigen-binding sites**, allowing it to bind multiple antigens on a surface - This **multivalency** enables formation of stable antigen-antibody complexes, creating an efficient platform for **C1q binding** - A **single IgM molecule** bound to antigen provides sufficient binding sites for activating C1q, making it the **most efficient** activator of the classical complement pathway - Its pentameric structure means it requires only **one molecule** to initiate complement activation *IgG* - IgG is a **monomer** and the **most abundant** serum immunoglobulin - Requires **at least two IgG molecules in close proximity** on an antigen surface to effectively activate the classical complement pathway - While it **can activate** the classical pathway, it is **less efficient per molecule** than pentameric IgM due to lower avidity for C1q *IgA* - Primarily functions in **mucosal immunity** (secretory IgA in saliva, tears, respiratory and GI tract) - **Poor activator** of the classical complement pathway - Can activate the **alternative pathway** of complement, but minimal role in classical pathway compared to IgM and IgG *IgD* - Primarily found on the **surface of naïve B lymphocytes** as a B cell receptor - Limited role as a **secreted antibody** in serum - **Does not activate** the complement pathway (neither classical nor alternative)
Explanation: ***C3b*** - **C3b** is a key complement component that **binds to microbial surfaces**, marking them for phagocytosis by immune cells. - Phagocytic cells, such as macrophages and neutrophils, have **receptors for C3b**, facilitating the engulfment and destruction of pathogens. *C3a (anaphylatoxin)* - **C3a** is an **anaphylatoxin** that mediates inflammation by causing mast cell degranulation and smooth muscle contraction. - It does not directly participate in **opsonization**, which is the process of marking pathogens for phagocytosis. *C5a (anaphylatoxin)* - **C5a** is a potent **anaphylatoxin** and **chemoattractant** for neutrophils and macrophages, promoting inflammation. - While it recruits phagocytes, it does not directly coat pathogens to enhance their uptake, which is the role of opsonins. *C5b (initiates MAC formation)* - **C5b** initiates the formation of the **membrane attack complex (MAC)** by assembling with other complement components (C6, C7, C8, C9). - The MAC creates pores in pathogen membranes, leading to **cell lysis**, but C5b itself does not function as an opsonin.
Cells and Organs of Immune System
Practice Questions
Innate Immunity
Practice Questions
Adaptive Immunity
Practice Questions
Antigens and Antibodies
Practice Questions
Major Histocompatibility Complex
Practice Questions
Complement System
Practice Questions
Cytokines and Chemokines
Practice Questions
Hypersensitivity Reactions
Practice Questions
Autoimmunity and Autoimmune Diseases
Practice Questions
Immunodeficiency Disorders
Practice Questions
Transplantation Immunology
Practice Questions
Tumor Immunology
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free